» Authors » Marc G Vervloet

Marc G Vervloet

Explore the profile of Marc G Vervloet including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 122
Citations 2783
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
11.
Jansen H, van Herwaarden A, Huijgen H, Vervloet M, Hillebrand J, Boelen A, et al.
Clin Chem Lab Med . 2023 Mar; 61(8):1436-1445. PMID: 36877870
Objectives: Hormone measurements using automated immunoassays (IAs) can be affected by the sample matrix. Liquid chromatography tandem-mass spectrometry (LC-MS/MS) is less affected by these matrix effects. In clinical laboratories, testosterone,...
12.
Vermeulen E, Vervloet M
Nutrients . 2023 Feb; 15(3). PMID: 36771254
Awareness of the clinical relevance of magnesium in medicine has increased over the last years, especially for people with chronic kidney disease (CKD), due to magnesium's role in vascular calcification...
13.
Leenders N, Douma C, Hoenderop J, Vervloet M
BMJ Open . 2022 Nov; 12(11):e063524. PMID: 36410806
Introduction: People treated with haemodialysis are at increased risk for all-cause and cardiovascular mortality. Plasma magnesium concentration has been inversely associated with these risks. Therefore, plasma magnesium may be a...
14.
Weiner D, Vervloet M, Walpen S, Schaufler T, Munera C, Menzaghi F, et al.
Kidney Med . 2022 Oct; 4(10):100542. PMID: 36185706
Rationale & Objective: Individuals with chronic kidney disease frequently suffer from chronic kidney disease-associated pruritus (CKD-aP), impacting sleep quality and quality of life (QoL) and increasing the likelihood of depression....
15.
Vermeulen E, Eelderink C, Hoekstra T, van Ballegooijen A, Raijmakers P, Beulens J, et al.
Trials . 2022 Sep; 23(1):769. PMID: 36096824
Background: Arterial stiffness and calcification propensity are associated with high cardiovascular risk and increased mortality in chronic kidney disease (CKD). Both magnesium and phosphate are recognized as modulators of vascular...
16.
Sundstrom J, Bodegard J, Bollmann A, Vervloet M, Mark P, Karasik A, et al.
Lancet Reg Health Eur . 2022 Sep; 20:100438. PMID: 36090671
Background: Digital healthcare systems data could provide insights into the global prevalence of chronic kidney disease (CKD). We designed the CaReMe CKD study to estimate the prevalence, key clinical adverse...
17.
Vervloet M
Metabolites . 2022 May; 12(5). PMID: 35629904
Early research has suggested a rather straightforward relation between phosphate exposure, increased serum FGF23 (Fibroblast Growth Factor 23) concentrations and clinical endpoints. Unsurprisingly, however, subsequent studies have revealed a much...
18.
Leenders N, Bos C, Hoekstra T, Schurgers L, Vervloet M, Hoenderop J
Nephrol Dial Transplant . 2022 Feb; 37(6):1049-1058. PMID: 35134986
Background: Vascular calcification is a key process involved in cardiovascular morbidity and mortality in patients with chronic kidney disease (CKD). Magnesium supplementation may counteract vascular calcification. In this study we...
19.
Neradova A, Wasilewski G, Prisco S, Leenders P, Caron M, Welting T, et al.
Nephrol Dial Transplant . 2021 Oct; 37(4):652-662. PMID: 34718756
Background: Hyperphosphataemia is strongly associated with cardiovascular disease and mortality. Recently, phosphate binders (PBs), which are used to bind intestinal phosphate, have been shown to bind vitamin K, thereby potentially...
20.
Vermeulen E, De Jong H, Blomjous A, Eelderink C, Hoekstra T, Elders P, et al.
Eur J Nutr . 2021 Sep; 61(2):653-664. PMID: 34491389
Purpose: Circulating and dietary magnesium have been shown to be inversely associated with the prevalence of cardiovascular disease (CVD) and mortality in both high and low-risk populations. We aimed to...